Dora Mitchell

Before joining Interius, Dora served as Vice President of Business Development and Vice President of Operations of Carisma Therapeutics, where she was on the founding team. Prior to the launch of Carisma, Dora managed a portfolio of 60 startup companies at PCI Ventures at the University of Pennsylvania as Director of the UPstart Company Incubator, often acting as “entrepreneur-in-residence” for companies in the life sciences portfolio. She has held roles spanning pre-clinical, early clinical, management and board positions in young companies including NellOne Therapeutics, Cognizance Biomarkers (acquired), CytoVas, LignaMed, Linnaeus Therapeutics Inc., Quantitative Radiology Solutions and Ophidion, Inc. Dora fell in love with early-stage companies while a member of the Health and Life Sciences team at Battelle Ventures, LP, early-stage life science and technology venture capital fund. She serves as founding investment committee member of Nassau Street Ventures. Dora holds a PhD in Molecular Biology from Princeton University.